Henry Schein Inc
HSIC- Exchange
- Nasdaq
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- SEC CIK
- 0001000228
No open-market purchases or sales by Henry Schein Inc insiders were filed in the last 90 days; 568 institutions reported holding it in 13F filings for Q2 2026, worth $10.3B in total; superinvestors Greenlight Capital and Southeastern Asset Management (Longleaf) hold it.
13F holders, Q1 2024
Institutional positions in Henry Schein Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 542
- −14 vs. Q4 2023
- Shares held
- 126.3M
- +355.6K (+0.3%) vs. Q4 2023
- Total value
- $9.53B
- −$103.8K (0.0%) vs. Q4 2023
- New holders
- 47
- 166 more added
- Sold out
- 61
- 224 more reduced
9 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HSIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 568 | $10.3B |
| Q1 2026 | 565 | $8.86B |
| Q4 2025 | 546 | $9.15B |
| Q3 2025 | 552 | $8.45B |
| Q2 2025 | 560 | $9.90B |
| Q1 2025 | 557 | $8.70B |
| Q4 2024 | 541 | $8.86B |
| Q3 2024 | 530 | $9.47B |
| Q2 2024 | 555 | $8.08B |
| Q1 2024 | 542 | $9.53B |
| Q4 2023 | 565 | $9.55B |
| Q3 2023 | 557 | $9.11B |
| Q2 2023 | 562 | $10.2B |
| Q1 2023 | 576 | $10.5B |
| Q4 2022 | 587 | $10.3B |
| Q3 2022 | 567 | $8.71B |
| Q2 2022 | 579 | $10.1B |
| Q1 2022 | 597 | $11.5B |
| Q4 2021 | 561 | $10.3B |
| Q3 2021 | 533 | $10.2B |
| Q2 2021 | 554 | $9.91B |
| Q1 2021 | 523 | $9.42B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Henry Schein Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Asset Dedication, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Transamerica Financial Advisors, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Ardevora Asset Management LLP | – | – | – | – | Not filed |
| Lee Danner & Bass Inc | – | – | – | – | Not filed |
| Sonen Capital LLC | – | – | – | – | Not filed |
| Bartlett & Co. LLC | – | – | – | – | Not filed |
| Desjardins Global Asset Management Inc. | – | – | – | – | Not filed |
| Moreno Evelyn V | – | – | – | – | Not filed |
| Neo Ivy Capital Management | – | – | – | – | Not filed |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |